Andrew D. Dickinson - 10 Jun 2022 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role: Chief Financial Officer
Signature: /s/ Edward S. Son by Power of Attorney for Andrew D. Dickinson
Issuer symbol: GILD
Transactions as of: 10 Jun 2022
Net transactions value: -$119,597
Form type: 4
Filing time: 13 Jun 2022, 20:13:44 UTC
Previous filing: 15 Mar 2022
Next filing: 12 Sep 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GILD	Common Stock	Options Exercise		+3,646	+5.7%		67,999	10 Jun 2022	Direct	F1
transaction	GILD	Common Stock	Options Exercise		+1,026	+1.5%		69,025	10 Jun 2022	Direct	F1
transaction	GILD	Common Stock	Tax liability	$119,597	-1,969	-2.9%	$60.74	67,056	10 Jun 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GILD	Restricted Stock Unit	Options Exercise		-3,646	-6.9%		49,478	10 Jun 2022	Common Stock	3,646		Direct	F1, F2
transaction	GILD	Restricted Stock Unit	Options Exercise		-1,026	-2.1%		48,452	10 Jun 2022	Common Stock	1,026		Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2	The restricted stock units have a four year vesting schedule. 25% vest on the anniversary of the date of grant until fully vested.
F3	The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.